Achieve Life Sciences, Inc. (ACHV) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Achieve Life Sciences, Inc. (ACHV) closed at USD 7.00 on 2026-10-14, a change of +46.4 % over the past year, with a market capitalization of USD 718.62M.

Achieve Life Sciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Achieve Life Sciences, Inc. key figures

Previous close

USD 7.00 (2026-10-14)

1-year change

+46.4 %

Market cap

USD 718.62M

Enterprise value

USD 544.88M

P/E ratio (trailing)

-4.15

P/E ratio (forward)

-10.68

EPS (trailing)

-1.68

EPS (forward)

-0.65

PEG ratio

17.68

Price to book

-48.74

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

10.47

Employees

28

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Achieve Life Sciences, Inc. and compare it with other stocks.